StockPriceToday
Atlassian Corp (TEAM)
About Atlassian Corp
Atlassian Corporation develops collaboration and productivity software solutions for software developers, project managers, and teams worldwide. The company's focus on team collaboration and agile development has made TEAM stock price sensitive to enterprise software adoption and remote work trends.
Atlassian's flagship products include Jira for project tracking, Confluence for team collaboration, and Bitbucket for code repository management, serving thousands of organizations globally. The company's tools enable software development teams to plan, track, and release software more efficiently.
The company's cloud-based software-as-a-service model creates predictable recurring revenue while enabling rapid product innovation and deployment. Atlassian's marketplace ecosystem allows third-party developers to extend platform functionality, enhancing customer value and retention, influencing TEAM stock price performance.
Atlassian's expansion into enterprise service management and work management demonstrates its commitment to serving broader organizational needs beyond software development teams. The company's ability to scale its platform while maintaining its culture of innovation remains important for its long-term growth and market leadership.
TEAM Stock 12 Month Chart
Latest News for TEAM
Wells Fargo raised its Atlassian target from USD 180 to USD 230 on October 14, 2026. Fiscal fourth-quarter revenue reached USD 1.77 billion against USD 1.66 billion of consensus estimates. Atlassian ...
Atlassian (TEAM) stock closed at its high in October 2021, and it currently trades at less than half that price. Investors and market watchers often treat that old close as a baseline for where the ...
Atlassian Corporation (NASDAQ: TEAM) closed at $207.75 on October 12. The stock has returned approximately 239% over the past six months, compared to a 21.25% return for the Insider Monkey Billionaire ...
Other Popular Stocks
BridgeBio Pharma Inc. is a biotechnology company developing therapies for genetic diseases and cancers using precision medicine approaches.
TaskUs Inc. (TASK) is a leading provider of outsourced digital services and next-generation customer experience solutions, serving high-growth technology companies with content moderation, customer...
Werewolf Therapeutics Inc. (HOWL) is a biotechnology company developing conditionally activated therapeutics for cancer treatment using innovative protein engineering.